In addition to the end of the shortage, Eli Lilly announced its intent to reduce prices for Zepbound, offering single-dose vials at $499 per month, down from $699, to keep pricing competitive
Very happy with the quality and will continue to order from them
BPC-157 may reduce pain perception for some users, but it should not be relied upon as primary pain management
Dihexa (CAS 1401708-83-5, also labeled PNB-0408) has never been studied in a placebo-controlled human trial, so there is no clinically established onset window for it at all
A compounded medication must not be described as FDA approved
Magnesium does not directly amplify semaglutide's weight loss mechanism, but it supports metabolic health and helps manage side effects like constipation that can occur during GLP-1 therapy